BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23617605)

  • 1. Slow and continuous delivery of a low dose of nimodipine improves survival and electrocardiogram parameters in rescue therapy of mice with experimental cerebral malaria.
    Martins YC; Clemmer L; Orjuela-Sánchez P; Zanini GM; Ong PK; Frangos JA; Carvalho LJ
    Malar J; 2013 Apr; 12():138. PubMed ID: 23617605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artemether and artesunate show the highest efficacies in rescuing mice with late-stage cerebral malaria and rapidly decrease leukocyte accumulation in the brain.
    Clemmer L; Martins YC; Zanini GM; Frangos JA; Carvalho LJ
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1383-90. PubMed ID: 21220531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transdermal glyceryl trinitrate as an effective adjunctive treatment with artemether for late-stage experimental cerebral malaria.
    Orjuela-Sánchez P; Ong PK; Zanini GM; Melchior B; Martins YC; Meays D; Frangos JA; Carvalho LJ
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5462-71. PubMed ID: 23979751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further evidence for an anti-inflammatory role of artesunate in experimental cerebral malaria.
    Miranda AS; Brant F; Rocha NP; Cisalpino D; Rodrigues DH; Souza DG; Machado FS; Rachid MA; Teixeira AL; Campos AC
    Malar J; 2013 Nov; 12():388. PubMed ID: 24180288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cysteamine broadly improves the anti-plasmodial activity of artemisinins against murine blood stage and cerebral malaria.
    Moradin N; Torre S; Gauthier S; Tam M; Hawari J; Vandercruyssen K; De Spiegeleer B; Fortin A; Stevenson MM; Gros P
    Malar J; 2016 May; 15(1):260. PubMed ID: 27150250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral activated charcoal prevents experimental cerebral malaria in mice and in a randomized controlled clinical trial in man did not interfere with the pharmacokinetics of parenteral artesunate.
    de Souza JB; Okomo U; Alexander ND; Aziz N; Owens BM; Kaur H; Jasseh M; Muangnoicharoen S; Sumariwalla PF; Warhurst DC; Ward SA; Conway DJ; Ulloa L; Tracey KJ; Foxwell BM; Kaye PM; Walther M
    PLoS One; 2010 Apr; 5(4):e9867. PubMed ID: 20419161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral artesunate prevents Plasmodium berghei Anka infection in mice.
    Gumede B; Folb P; Ryffel B
    Parasitol Int; 2003 Mar; 52(1):53-9. PubMed ID: 12543147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of cerebrovascular constriction in experimental cerebral malaria by L-arginine.
    Ong PK; Moreira AS; Daniel-Ribeiro CT; Frangos JA; Carvalho LJM
    Sci Rep; 2018 Oct; 8(1):15957. PubMed ID: 30374028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel ETA receptor antagonist HJP-272 prevents cerebral microvascular hemorrhage in cerebral malaria and synergistically improves survival in combination with an artemisinin derivative.
    Dai M; Freeman B; Bruno FP; Shikani HJ; Tanowitz HB; Weiss LM; Reznik SE; Stephani RA; Desruisseaux MS
    Life Sci; 2012 Oct; 91(13-14):687-92. PubMed ID: 22820174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of intranasal administration of artesunate in experimental cerebral malaria.
    Marijon A; Bonnot G; Fourier A; Bringer C; Lavoignat A; Gagnieu MC; Bienvenu AL; Picot S
    Malar J; 2014 Dec; 13():501. PubMed ID: 25516091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine cerebral malaria is associated with a vasospasm-like microcirculatory dysfunction, and survival upon rescue treatment is markedly increased by nimodipine.
    Cabrales P; Zanini GM; Meays D; Frangos JA; Carvalho LJ
    Am J Pathol; 2010 Mar; 176(3):1306-15. PubMed ID: 20110412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artesunate-erythropoietin combination for murine cerebral malaria treatment.
    Bienvenu AL; Ferrandiz J; Kaiser K; Latour C; Picot S
    Acta Trop; 2008 May; 106(2):104-8. PubMed ID: 18359468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of artesunate combined with Atractylodes lancea or Prabchompoothaweep remedy extracts as adjunctive therapy for the treatment of cerebral malaria.
    Plirat W; Chaniad P; Phuwajaroanpong A; Konyanee A; Viriyavejakul P; Septama AW; Punsawad C
    BMC Complement Med Ther; 2023 Sep; 23(1):332. PubMed ID: 37730604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of hydrogen sulfide gas as a treatment against P. falciparum, murine cerebral malaria, and the importance of thiolation state in the development of cerebral malaria.
    DellaValle B; Staalsoe T; Kurtzhals JA; Hempel C
    PLoS One; 2013; 8(3):e59271. PubMed ID: 23555646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Protective effects of artesunate combination on experimental cerebral malaria and nerve injury].
    Jiang XH; Chen LN; Li K; Guo Y; Zheng ZY; Yang T; Zheng XJ; Li YJ; Zhu XX
    Zhongguo Zhong Yao Za Zhi; 2018 Aug; 43(15):3051-3057. PubMed ID: 30200698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artesunate and erythropoietin synergistically improve the outcome of experimental cerebral malaria.
    Du Y; Chen G; Zhang X; Yu C; Cao Y; Cui L
    Int Immunopharmacol; 2017 Jul; 48():219-230. PubMed ID: 28531845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S1P is associated with protection in human and experimental cerebral malaria.
    Finney CA; Hawkes CA; Kain DC; Dhabangi A; Musoke C; Cserti-Gazdewich C; Oravecz T; Liles WC; Kain KC
    Mol Med; 2011; 17(7-8):717-25. PubMed ID: 21556483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanostructured lipid carriers of artemether-lumefantrine combination for intravenous therapy of cerebral malaria.
    Prabhu P; Suryavanshi S; Pathak S; Patra A; Sharma S; Patravale V
    Int J Pharm; 2016 Nov; 513(1-2):504-517. PubMed ID: 27596113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety evaluation of a novel trioxaquine in the management of cerebral malaria in a mouse model.
    Odhiambo OC; Wamakima HN; Magoma GN; Kirira PG; Malala BJ; Kimani FT; Muregi FW
    Malar J; 2017 Jul; 16(1):268. PubMed ID: 28673299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From METS to malaria: RRx-001, a multi-faceted anticancer agent with activity in cerebral malaria.
    Yalcin O; Oronsky B; Carvalho LJ; Kuypers FA; Scicinski J; Cabrales P
    Malar J; 2015 May; 14():218. PubMed ID: 26017006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.